Clinical Trial Search

Primary: Primary Objective Foam Sanitizer User Touch and Feel Experience — 53.21; 39.62; 61.21; 49.73 score on a scale

Primary: Microorganisms on Hands Before Scrubbing — 28.99; 38.64; 22.91 colony forming unit

Primary: Foam Sanitizer Wet Time Duration — 35.41 time in seconds

Primary: Control Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's Hands — 589.3 Colony forming units

Primary: Number of Participants With Composite Compliance With Expected Infection Prevention Practices Upon Entry to Contact Precaution-patient Rooms — 1297; 954 Participants

Primary: Surgical Site Infection — 128; 127 Participants — p=<0.05

Primary: Number of Participants With Postoperative Healthcare Acquired Infections — 108; 116 Participants

Primary: Bacterial Colony Forming Units Present on Hand Prints After Time Spent in Common Areas — 2.17; 1.81 log(10) transformed CFU

Primary: Investigator Global Assessment — 1.0; 1.1 units on a scale

Primary: Hand Hygiene Compliance — -0.4; 1.8; -1.3; -3.7 percentage of change in HH compliance

Primary: Difference in % Reduction in Wart Size Between Product A and Product B at Each Timepoint

Primary: Change From Baseline in Skin Health, Visual Skin Score (VSS) at 14 Days — 0.1; 0.4 units on a scale

Primary: The Five Facet Mindfulness Questionnaire (FFMQ) - Post-Intervention — 3.46; 3.35 units on a scale

Primary: Amount of Diethylhexyl Phthalate Removed From Hand — 94.64; 8.74 percentage of DEHP removed

Primary: Number of Central Venous Catheter Hubs With Internal Contamination — 42; 18; 39; 14 contaminated hubs

Primary: Number of Participants With a Clinical Cure — 45; 42 Participants — p=0.71

Primary: Number of Participants With a Superficial Incisional Surgical Site Infection (SSI) — 20; 27; 6; 9 Participants

Primary: Medline 2% CHG Cloth Dosage of Coverage Area — 0.0081 g/cm^2

Primary: Log Reduction of Bacterial Flora on the Abdomen and Groin — 1.9; 2.0; 1.3; 1.9 Log10 Reductions

Primary: Incidence of Surgical Site Infections — 0; 0 Participants

Primary: The Primary Objective of This Trial is to Compare the Impact of Disinfecting the Skin With Chloraprep vs. Betadine on the Rates of Infection of Clean-contaminated…

Primary: Evaluate the Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Administered Topically — 24; 48; 24 (CFU/cm2) — p=<0.05

Primary: Number of Subjects With Plasma Levels of Chlorexidine Following Systemic Exposure After a Single Topical Application of CHG. — 0; 0; 0 Participants

Primary: Number of Patients With a Clinically Diagnosed Infection — 0; 0 participants

Primary: Change in the Release of Skin Flora From the Hands From Baseline to 5 Minutes After Disinfection by Surgical Scrubbing (Time Frame- "Baseline and 5 Minutes"). — 3.96…

Primary: Number of Catheter-Related Blood Stream Infections (CRBSI) at 6 Months — 1.98; 2.09; 1.73; 1.02 Infections per 1000 days with catheter

Primary: Relative GAS Survival — 100; 75; 90 percentage overall bacterial abundance

Primary: Antimicrobial Activity of the Investigational Products Compared to Control. — 3.85; 3.91; 3.87; 3.84 log10 CFU/cm^2

Primary: Primary Outcome Measure for Efficacy (IGA) — 2.33; 2.20; 2.43; 2 score on a scale

Primary: Number of Participants With a Superficial Incisional Surgical Site Infection (SSI) — 13; 7 Participants